Mecoceff CV 162.5 is a broad-spectrum antibiotic combination used for the effective treatment of various bacterial infections affecting the respiratory tract, ear, nose, throat, urinary tract, skin, and soft tissues. It helps eliminate infection-causing bacteria and prevents their further growth and spread, ensuring faster recovery from bacterial illnesses.

This formulation contains Cefpodoxime Proxetil 100 mg and Clavulanic Acid 62.5 mg per tablet. Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Clavulanic Acid is a beta-lactamase inhibitor that enhances the effectiveness of Cefpodoxime by preventing bacterial resistance.

Mecoceff CV 162.5 is commonly prescribed for conditions such as tonsillitis, pharyngitis, sinusitis, bronchitis, pneumonia, otitis media, urinary tract infections, and skin infections. It should be taken strictly as prescribed by a physician, and the full course must be completed even if symptoms improve early to prevent recurrence and antibiotic resistance.